A pilot study employing hepatic intra-arterial irinotecan injection of drug-eluting beads as salvage therapy in liver metastatic colorectal cancer patients without extrahepatic involvement: the first southern Italy experience

Cancer Patients ◽

Salvage Therapy ◽

Southern Italy ◽

Drug Eluting Beads ◽

Drug Eluting ◽

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

British Journal of Cancer ◽

10.1038/s41416-019-0537-z ◽

2019 ◽

Vol 121 (5) ◽

pp. 378-383 ◽

Cited By ~ 1

Author(s):

Elena Elez ◽

Carles Pericay ◽

Manuel Valladares-Ayerbes ◽

Inmaculada Bando ◽

Maria Jose Safont ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Salvage Therapy ◽

Phase 2 ◽

Wild Type ◽

Exon 2 ◽

Phase 2 Study ◽

Colorectal Cancer Patients ◽

Kras Exon

Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-008-0454-7 ◽

2008 ◽

Vol 135 (2) ◽

pp. 217-226 ◽

Cited By ~ 31

Author(s):

Pasquale Comella ◽

Bruno Massidda ◽

Gianfranco Filippelli ◽

Antonio Farris ◽

Donato Natale ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Southern Italy ◽

Randomised Trial ◽

Oral Capecitabine ◽

Abstract 4131: Genetic variant associations with treatment outcome and safety in metastatic colorectal cancer patients treated with sorafenib and bevacizumab (BEV) as salvage therapy

10.1158/1538-7445.am2011-4131 ◽

2011 ◽

Author(s):

Jacqueline M. Lafky ◽

Brian M. Bot ◽

Bruce W. Morlan ◽

Axel Grothey

Keyword(s):

Colorectal Cancer ◽

Treatment Outcome ◽

Cancer Patients ◽

Salvage Therapy ◽

Genetic Variant ◽

Role of single nucleotide polymorphisms of gemcitabine metabolic genes in metastatic colorectal cancer patients treated with gemcitabine-based salvage therapy.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e13579 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e13579-e13579

Author(s):

J. Rodriguez ◽

E. Bandres ◽

A. Hernandez ◽

R. Zarate ◽

V. Boni ◽

...

Keyword(s):

Colorectal Cancer ◽

Single Nucleotide Polymorphisms ◽

Cancer Patients ◽

Salvage Therapy ◽

Nucleotide Polymorphisms ◽

Single Nucleotide ◽

Metabolic Genes ◽

A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study

International Journal of Cancer ◽

10.1002/ijc.33303 ◽

2020 ◽

Author(s):

Matthias Unseld ◽

Jelena Belic ◽

Kerstin Pierer ◽

Qing Zhou ◽

Tina Moser ◽

...

Keyword(s):

Colorectal Cancer ◽

Pilot Study ◽

Cancer Patients ◽

Phase Ii ◽

Liquid Biopsy ◽

Resilience and hope during advanced disease: a pilot study with metastatic colorectal cancer patients

BMC Palliative Care ◽

10.1186/s12904-016-0139-y ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 19

Author(s):

Joao Paulo Consentino Solano ◽

Amanda Gomes da Silva ◽

Ivan Agurtov Soares ◽

Hazem Adel Ashmawi ◽

Joaquim Edson Vieira

Keyword(s):

Colorectal Cancer ◽

Pilot Study ◽

Cancer Patients ◽

Advanced Disease ◽

Weekly Oxaliplatin, High-Dose Folinic Acid and 24h-5-fluorouracil (FUFOX) as Salvage Therapy in Metastatic Colorectal Cancer Patients Pretreated with Irinotecan and Folinic Acid/5-Fluorouracil Regimens

Zeitschrift für Gastroenterologie ◽

10.1055/s-2002-36156 ◽

2002 ◽

Vol 40 (12) ◽

pp. 957-964 ◽

Cited By ~ 12

Author(s):

M Moehler ◽

T Hoffmann ◽

K Hildner ◽

J Siebler ◽

P R Galle ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Salvage Therapy ◽

High Dose ◽

A multistep therapy with subcutaneous low dose recombinant interleukin-2, 5-fluorouracil and leucovorin prolongs the response of metastatic colorectal cancer patients: a pilot study

Biomedicine & Pharmacotherapy ◽

10.1016/s0753-3322(98)80027-9 ◽

1998 ◽

Vol 52 (7-8) ◽

pp. 311-316 ◽

Cited By ~ 6

Author(s):

A Nicolini ◽

A Carpi ◽

P Ferrari ◽

A Sagripanti ◽

L Anselmi

Keyword(s):

Colorectal Cancer ◽

Pilot Study ◽

Cancer Patients ◽

Low Dose ◽

Interleukin 2 ◽

Recombinant Interleukin 2 ◽

Faculty Opinions recommendation of Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726943980.793538773 ◽

2017 ◽

Author(s):

Noelle LoConte ◽

Kieran Sahasrabudhe

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Iii ◽

First Line ◽

Phase Iii Study ◽

Colorectal Cancer Patients ◽

Line Chemotherapy

A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed

European Journal of Cancer ◽

10.1016/s0959-8049(01)81579-3 ◽

2001 ◽

Vol 37 ◽

pp. S294-S295

Author(s):

G. Masi ◽

A. Di Paolo ◽

G. Allegrini ◽

S. Cupini ◽

C. Galli ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Continuous Infusion ◽

Cancer Patients ◽

Pharmacokinetic Study ◽